Skip to content

WAVES shows elvitegravir regimen beats boosted atazanavir for women with HIV

Open-label PrEP in Botswana: very high adherence and no HIV infections seen

Faith Henderson at IAS 2015 photo ©Marcus Rose/IAS

Peer or community interventions improve outcomes for mothers with HIV

Retention in pre-ART care can be boosted by monthly visits from volunteer support workers

Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme

Dominique Salmon at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies

David Wyles at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Intensification of antiretroviral therapy reduces risk of late-term mother-to-child HIV transmission

Implant and injectable hormonal contraception most effective methods for women living with HIV

Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection

Laurence Brunet at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.com